Truveris
New York, US · Delaware corporation · 5 known investors
Data-driven platform bringing transparency to prescription drug ecosystem for employers, retailers, and manufacturers.
Founders & leadership
PC
Philippe ChambonDirector
SM
Stephen M. BlochDirector
BH
Brian HirschDirector
MF
Michael FacendolaExecutive Officer
MR
Marcia RadosevichExecutive Officer
LG
Leon GreeneDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$24.7MraisedAug 2017 · 10 investors · Other TechnologyRule 506(b)
▶$24.7MraisedAug 2017 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael FacendolaExecutive Officer
- Anthony LoiaconoDirector
- Matthew SimasDirector
- Brian HirschDirector
- Stephen M. BlochDirector
- Vijay LathiDirector
- Faisal MushtaqExecutive Officer, Director
- Offering amount
- $34.7M
- Amount sold
- $24.7M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedMar 2016 · 5 investors · Other TechnologyRule 506(b)
▶$2.5MraisedMar 2016 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Philippe ChambonDirector
- Stephen M. BlochDirector
- Brian HirschDirector
- Michael FacendolaExecutive Officer
- Marcia RadosevichExecutive Officer
- Leon GreeneDirector
- Offering amount
- $10M
- Amount sold
- $2.5M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.